![]() |
인쇄하기
취소
|
An explosion at the Tianjin Port in China has caused difficulties in supplying a part of GSK’s products to the domestic market.
According to the industry concerned on the 7th, the problematic product is ‘Zantac,’ a stomach medicine(OTC) and ‘Hepsera(adefovir),’ a hepatitis B treatment.
Products of Zantac, particularly, are expected to be in short supply soon. As changed from ETC to OTC, the d...